STAT+ | A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come

The expected launch of daraxonrasib, a drug developed by Revolution Medicines, will likely deliver both opportunities and challenges

By Andrew Joseph

FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientist

Former FDA toxicologist says Zyn nicotine pouches were authorized without knowing what they're made of, raises concerns about microplastics.

By Matthew Chapman and Kathryn Kranhold — The Examination

12 ideas for tackling the U.S. alcohol epidemic

Final installment of 'Deadliest Drug' series on the public health costs of alcohol. Knowing Prohibition was a failure, experts have a dozen other ideas.

By Isabella Cueto and Lev Facher

Julia Bujalski/STAT

STAT+ | 10 charts that explain America’s hidden alcohol epidemic

A deep dive into why America has a public health blind spot on alcohol: An all-charts look from the special STAT series "Deadliest Drug."

By J. Emory Parker, Lev Facher, and Isabella Cueto

More around STAT

In other news

Astra Gets Chinese Firm’s Lung Cancer Drug In $1.5 Billion Deal
Astra to pay China’s Dizal Jiangsu Pharmaceutical Co. for global rights to a lung cancer drug, in a $1.5B deal, Bloomberg
931 days. The drug approval scandal hiding in plain sight, STAT
People in Thornton-Cleveleys want answers on the health impact of a neighborhood chemical plant, The Guardian
Cancer centers ration chemotherapy and generics amid new shortages, Axios

Play: What's the word? Test your knowledge with today's mini crossword

STAT, 1 Exchange Place, Boston, MA

I no longer wish to receive STAT emails

Update Newsletter Preferences • Contact Us • Advertise with Us • View in Browser